BRUNSWICK CORP (BC) Fundamental Analysis & Valuation

NYSE:BC • US1170431092

Current stock price

77.06 USD
-0.93 (-1.19%)
At close:
77.06 USD
0 (0%)
After Hours:

This BC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BC Profitability Analysis

1.1 Basic Checks

  • In the past year BC was profitable.
  • BC had a positive operating cash flow in the past year.
  • BC had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years BC had a positive operating cash flow.
BC Yearly Net Income VS EBIT VS OCF VS FCFBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

1.2 Ratios

  • BC has a Return On Assets (-2.58%) which is comparable to the rest of the industry.
  • BC has a Return On Equity of -8.45%. This is comparable to the rest of the industry: BC outperforms 40.63% of its industry peers.
  • BC has a better Return On Invested Capital (5.91%) than 65.63% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BC is in line with the industry average of 7.55%.
Industry RankSector Rank
ROA -2.58%
ROE -8.45%
ROIC 5.91%
ROA(3y)2.15%
ROA(5y)5.62%
ROE(3y)6.19%
ROE(5y)16.54%
ROIC(3y)8.7%
ROIC(5y)11.18%
BC Yearly ROA, ROE, ROICBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • BC has a better Operating Margin (5.83%) than 75.00% of its industry peers.
  • In the last couple of years the Operating Margin of BC has declined.
  • BC's Gross Margin of 24.84% is on the low side compared to the rest of the industry. BC is outperformed by 62.50% of its industry peers.
  • BC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.83%
PM (TTM) N/A
GM 24.84%
OM growth 3Y-25.84%
OM growth 5Y-14.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.01%
GM growth 5Y-2.03%
BC Yearly Profit, Operating, Gross MarginsBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

4

2. BC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BC is destroying value.
  • BC has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BC has been reduced compared to 5 years ago.
  • Compared to 1 year ago, BC has an improved debt to assets ratio.
BC Yearly Shares OutstandingBC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
BC Yearly Total Debt VS Total AssetsBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 3.06 indicates that BC is not in any danger for bankruptcy at the moment.
  • BC's Altman-Z score of 3.06 is fine compared to the rest of the industry. BC outperforms 65.63% of its industry peers.
  • The Debt to FCF ratio of BC is 5.30, which is a neutral value as it means it would take BC, 5.30 years of fcf income to pay off all of its debts.
  • BC has a Debt to FCF ratio of 5.30. This is comparable to the rest of the industry: BC outperforms 56.25% of its industry peers.
  • BC has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.11, BC is doing worse than 65.63% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.3
Altman-Z 3.06
ROIC/WACC0.67
WACC8.8%
BC Yearly LT Debt VS Equity VS FCFBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • BC has a Current Ratio of 1.44. This is a normal value and indicates that BC is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.44, BC is doing worse than 62.50% of the companies in the same industry.
  • BC has a Quick Ratio of 1.44. This is a bad value and indicates that BC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.61, BC is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.61
BC Yearly Current Assets VS Current LiabilitesBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

4

3. BC Growth Analysis

3.1 Past

  • The earnings per share for BC have decreased strongly by -28.29% in the last year.
  • Measured over the past years, BC shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.40% on average per year.
  • Looking at the last year, BC shows a small growth in Revenue. The Revenue has grown by 2.40% in the last year.
  • Measured over the past years, BC shows a small growth in Revenue. The Revenue has been growing by 4.29% on average per year.
EPS 1Y (TTM)-28.29%
EPS 3Y-31.13%
EPS 5Y-8.4%
EPS Q2Q%141.67%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y-7.66%
Revenue growth 5Y4.29%
Sales Q2Q%15.49%

3.2 Future

  • Based on estimates for the next years, BC will show a very strong growth in Earnings Per Share. The EPS will grow by 27.86% on average per year.
  • Based on estimates for the next years, BC will show a small growth in Revenue. The Revenue will grow by 5.76% on average per year.
EPS Next Y33.56%
EPS Next 2Y28.22%
EPS Next 3Y27.67%
EPS Next 5Y27.86%
Revenue Next Year9.1%
Revenue Next 2Y7.1%
Revenue Next 3Y6.73%
Revenue Next 5Y5.76%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BC Yearly Revenue VS EstimatesBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
BC Yearly EPS VS EstimatesBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

5

4. BC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 23.57, which indicates a rather expensive current valuation of BC.
  • 62.50% of the companies in the same industry are more expensive than BC, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of BC to the average of the S&P500 Index (26.78), we can say BC is valued inline with the index average.
  • A Price/Forward Earnings ratio of 17.64 indicates a rather expensive valuation of BC.
  • BC's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BC is cheaper than 65.63% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of BC to the average of the S&P500 Index (23.54), we can say BC is valued slightly cheaper.
Industry RankSector Rank
PE 23.57
Fwd PE 17.64
BC Price Earnings VS Forward Price EarningsBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • BC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BC is cheaper than 65.63% of the companies in the same industry.
  • 75.00% of the companies in the same industry are more expensive than BC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.61
EV/EBITDA 11.41
BC Per share dataBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • BC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BC's earnings are expected to grow with 27.67% in the coming years.
PEG (NY)0.7
PEG (5Y)N/A
EPS Next 2Y28.22%
EPS Next 3Y27.67%

6

5. BC Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.48%, BC has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.26, BC pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, BC pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.48%

5.2 History

  • On average, the dividend of BC grows each year by 11.59%, which is quite nice.
  • BC has paid a dividend for at least 10 years, which is a reliable track record.
  • BC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.59%
Div Incr Years13
Div Non Decr Years17
BC Yearly Dividends per shareBC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • The earnings of BC are negative and hence is the payout ratio. BC will probably not be able to sustain this dividend level.
  • BC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-82.01%
EPS Next 2Y28.22%
EPS Next 3Y27.67%
BC Yearly Income VS Free CF VS DividendBC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

BC Fundamentals: All Metrics, Ratios and Statistics

BRUNSWICK CORP

NYSE:BC (4/10/2026, 8:07:24 PM)

After market: 77.06 0 (0%)

77.06

-0.93 (-1.19%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners104.78%
Inst Owner Change0%
Ins Owners0.93%
Ins Owner Change0.11%
Market Cap5.00B
Revenue(TTM)5.36B
Net Income(TTM)-137.30M
Analysts77.14
Price Target91.23 (18.39%)
Short Float %6.39%
Short Ratio3.97
Dividend
Industry RankSector Rank
Dividend Yield 2.48%
Yearly Dividend1.72
Dividend Growth(5Y)11.59%
DP-82.01%
Div Incr Years13
Div Non Decr Years17
Ex-Date02-23
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.15%
Min EPS beat(2)-2.34%
Max EPS beat(2)10.64%
EPS beat(4)3
Avg EPS beat(4)41.04%
Min EPS beat(4)-2.34%
Max EPS beat(4)136.9%
EPS beat(8)4
Avg EPS beat(8)19.7%
EPS beat(12)5
Avg EPS beat(12)11.6%
EPS beat(16)7
Avg EPS beat(16)8.89%
Revenue beat(2)2
Avg Revenue beat(2)5.84%
Min Revenue beat(2)4.71%
Max Revenue beat(2)6.96%
Revenue beat(4)4
Avg Revenue beat(4)7.35%
Min Revenue beat(4)4.71%
Max Revenue beat(4)12.87%
Revenue beat(8)5
Avg Revenue beat(8)2.39%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)6
Avg Revenue beat(16)-1.2%
PT rev (1m)1.09%
PT rev (3m)17.59%
EPS NQ rev (1m)5.94%
EPS NQ rev (3m)-37.35%
EPS NY rev (1m)0.33%
EPS NY rev (3m)2.32%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)0.74%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)3.48%
Valuation
Industry RankSector Rank
PE 23.57
Fwd PE 17.64
P/S 0.93
P/FCF 12.61
P/OCF 8.89
P/B 3.07
P/tB 55.77
EV/EBITDA 11.41
EPS(TTM)3.27
EY4.24%
EPS(NY)4.37
Fwd EY5.67%
FCF(TTM)6.11
FCFY7.93%
OCF(TTM)8.67
OCFY11.25%
SpS82.7
BVpS25.07
TBVpS1.38
PEG (NY)0.7
PEG (5Y)N/A
Graham Number42.95
Profitability
Industry RankSector Rank
ROA -2.58%
ROE -8.45%
ROCE 8.04%
ROIC 5.91%
ROICexc 6.33%
ROICexgc 10.98%
OM 5.83%
PM (TTM) N/A
GM 24.84%
FCFM 7.39%
ROA(3y)2.15%
ROA(5y)5.62%
ROE(3y)6.19%
ROE(5y)16.54%
ROIC(3y)8.7%
ROIC(5y)11.18%
ROICexc(3y)9.5%
ROICexc(5y)12.37%
ROICexgc(3y)18.05%
ROICexgc(5y)24.22%
ROCE(3y)11.84%
ROCE(5y)15.22%
ROICexgc growth 3Y-29.65%
ROICexgc growth 5Y-20.68%
ROICexc growth 3Y-27.91%
ROICexc growth 5Y-19.68%
OM growth 3Y-25.84%
OM growth 5Y-14.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.01%
GM growth 5Y-2.03%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.3
Debt/EBITDA 2.99
Cap/Depr 56.68%
Cap/Sales 3.09%
Interest Coverage 2.72
Cash Conversion 92.92%
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 0.61
Altman-Z 3.06
F-Score5
WACC8.8%
ROIC/WACC0.67
Cap/Depr(3y)73.55%
Cap/Depr(5y)107.72%
Cap/Sales(3y)3.6%
Cap/Sales(5y)4.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.29%
EPS 3Y-31.13%
EPS 5Y-8.4%
EPS Q2Q%141.67%
EPS Next Y33.56%
EPS Next 2Y28.22%
EPS Next 3Y27.67%
EPS Next 5Y27.86%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y-7.66%
Revenue growth 5Y4.29%
Sales Q2Q%15.49%
Revenue Next Year9.1%
Revenue Next 2Y7.1%
Revenue Next 3Y6.73%
Revenue Next 5Y5.76%
EBIT growth 1Y-27.9%
EBIT growth 3Y-31.52%
EBIT growth 5Y-10.54%
EBIT Next Year84.19%
EBIT Next 3Y32.29%
EBIT Next 5Y23.77%
FCF growth 1Y50.11%
FCF growth 3Y26.07%
FCF growth 5Y-8.44%
OCF growth 1Y30.3%
OCF growth 3Y-1.38%
OCF growth 5Y-6.78%

BRUNSWICK CORP / BC Fundamental Analysis FAQ

What is the fundamental rating for BC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BC.


What is the valuation status of BRUNSWICK CORP (BC) stock?

ChartMill assigns a valuation rating of 5 / 10 to BRUNSWICK CORP (BC). This can be considered as Fairly Valued.


Can you provide the profitability details for BRUNSWICK CORP?

BRUNSWICK CORP (BC) has a profitability rating of 4 / 10.


What is the expected EPS growth for BRUNSWICK CORP (BC) stock?

The Earnings per Share (EPS) of BRUNSWICK CORP (BC) is expected to grow by 33.56% in the next year.


Is the dividend of BRUNSWICK CORP sustainable?

The dividend rating of BRUNSWICK CORP (BC) is 6 / 10 and the dividend payout ratio is -82.01%.